J. Heuson

发表

Oestrogen receptors in breast cancer: a changing concept.

G. Leclercq, J. Heuson, M. Deboel, 1975, British medical journal.

Effects on insulin, prolactin, progesterone, and estradiol on DNA synthesis in organ culture of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.

J. Pasteels, J. Heuson-Stiennon, N. Legros, 1976, Cancer research.

Effects of 2-Br-alpha-Ergocryptine, L-dopa and cyclic imides on serum prolactin in postmenopausal women.

M. L'hermite, M. Rozencweig, C. Robyn, 1973, European journal of cancer.

Effects of aminoglutethimide plus hydrocortisone on the genital tract of postmenopausal women with advanced breast cancer. A clinical and cytologic survey.

R. Paridaens, V. Budel, J. Heuson, 1986, Anticancer research.

Assessment of response to therapy in advanced breast cancer. A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland.

R. Rubens, P. Carbone, J. Hayward, 1978, European journal of cancer.

Assessment of response to therapy in advanced breast cancer (an amendment)

R. Rubens, P. Carbone, J. Hayward, 1978, British Journal of Cancer.

Effects of a gonadotropin-releasing hormone (GnRH) analogue (A-43818) on 7, 12- dimethylbenz (a)anthracene-induced rat mammary tumors. Histological and endocrine studies.

J. Pasteels, J. Heuson-Stiennon, A. Danguy, 1977, European journal of cancer.

Morphology of MXT mouse mammary tumors. Correlation with growth characteristics and hormone sensitivity.

R. Kiss, J. Pasteels, G. Leclercq, 1986, European journal of cancer & clinical oncology.

Breast cancer : trends in research and treatment

M. Rozencweig, J. Heuson, W. Mattheiem, 1976 .

Contribution of Estrogen Receptors to the Strategy of Breast Cancer Treatment

R. Paridaens, R. Sylvester, G. Leclercq, 1981 .

Clinical significance of the quantitative assessment of estrogen receptors in advanced breast cancer

R. Paridaens, R. Sylvester, G. Leclercq, 1980, Cancer.

Effects of Bacillus Calmette-Guérin (BCG) infection on residual disease of the rat mammary tumor after ovariectomy.

N. Legros, W. Piessens, J. Heuson, 1971, European journal of cancer.

Facilitation of Rat Mammary Tumour Growth by BCG

F. Lachapelle, N. Legros, W. Piessens, 1970, Nature.

Assay for estrogen and progesterone receptors of breast cancer cell lines in monolayer culture.

G. Leclercq, N. Devleeschouwer, J. Heuson, 1985, European journal of cancer & clinical oncology.

Guide-lines in the design of new antiestrogens and cytotoxic-linked estrogens for the treatment of breast cancer.

G. Leclercq, N. Devleeschouwer, J. Heuson, 1983, Journal of steroid biochemistry.

EFFECTS OF AMINOGLUTETHIMIDE ON ADRENAL STEROID SECRETION

R. Paridaens, A. Vermeulen, J. Heuson, 1983, Clinical endocrinology.

Comparative trial of nafoxidine and ethinyloestradiol in advanced breast cancer: an E.O.R.T.C. study.

E. Engelsman, J. Heuson, J. Michel, 1975, British medical journal.

Effect of insulin and of alloxan diabetes on growth of the rat mammary carcinoma in vivo.

N. Legros, J. Heuson, 1970, European journal of cancer.

Proliferative effect of estradiol on the uterus and the mxt hormone dependent mammary tumor of the mouse. Abstr.

R. Paridaens, G. Leclercq, J. Werry, 1983 .

Assessment of estrogenic recruitment before chemotherapy in advanced breast cancer: a double-blind randomized study. European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group.

R. Paridaens, R. Sylvester, J. Julien, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Assessment of estrogenic recruitment before chemotherapy in advanced breast cancer: Preliminary results of a double-blind randomized study of the eortic breast cancer cooperative group

J. Klijn, R. Paridaens, R. Sylvester, 1990, Journal of Steroid Biochemistry and Molecular Biology.

Six‐year results of a multimodality treatment strategy for locally advanced breast cancer

M. Piccart, R. Paridaens, D. de Valeriola, 1988, Cancer.

Induction of progesterone receptor in an estrogen, progesterone receptor-negative breast cancer cell line.

G. Leclercq, N. Devleeschouwer, N. Legros, 1986, Journal of steroid biochemistry.

Effect of insulin on DNA synthesis and DNA polymerase activity in organ culture of rat mammary carcinoma, and the inflence of insulin pretreatment and of alloxan diabetes.

N. Legros, J. Heuson, 1971, Cancer research.

Hormones by administration

J. Heuson, 1974 .

Cisplatin plus vindesine in advanced breast cancer: a phase II trial of the EORTC Breast Cancer Cooperative Group.

R. Paridaens, M. Rozencweig, N. Rotmensz, 1985, European journal of cancer & clinical oncology.

Estrogenic and antiestrogenic down-regulation of estrogen receptor levels: evidence for two different mechanisms.

G. Leclercq, J. Heuson, M. Gyling, 1990, Journal of receptor research.

A new diagnostic and therapeutic approach fibrinolysis and hemorrhage.

J. Heuson, H. Tagnon, W. Peers, 1958, Blood.

Influence of insulin deprivation on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats subjected to alloxan diabetes and food restriction.

N. Legros, J. Heuson, 1972, Cancer research.

Disseminated candidiasis in heroin addicts. Report of two cases and review of the literature.

R. Paridaens, J. Heuson, C. Arrigo, 1986 .

Growth inhibition of rat mammary carcinoma and endocrine changes produced by 2-Br-alpha-ergocryptine, a suppressor of lactation and nidation.

N. Legros, J. Heuson, C. Waelbroeck-van Gaver, 1970, European journal of cancer.

Antitumour effect of cyclofenil (F6066) on DMBA-induced rat mammary tumors.

G. Leclercq, A. Danguy, N. Devleeschouwer, 1978, European journal of cancer.

Estrogen receptors in the spectrum of breast cancer.

G. Leclercq, J. Heuson, 1976, Current problems in cancer.

Assessment of response to therapy in advanced breast cancer.

R. Rubens, P. Carbone, J. Hayward, 1977, British Journal of Cancer.

Ibenzmethyzin (Natulan), a highly effective mammary carcinogen in the Huggins system.

J. Heuson, R. Heimann, 1966, European journal of cancer.

N-(phosphonacetyl)-L-aspartate (PALA) in advanced breast cancer: a phase II trial of the EORTC breast cancer cooperative group.

R. Paridaens, R. Sylvester, H. Mouridsen, 1982, European journal of cancer & clinical oncology.

Effect of Bacillus Calmette-Guérin on mammary tumor formation and cellular immunity in dimethylbenz(a)anthracene-treated rats.

N. Legros, W. Piessens, J. Heuson, 1971, Cancer research.

Aromatase, 17 beta-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women.

J. Deslypere, R. Paridaens, G. Leclercq, 1986, European journal of cancer & clinical oncology.

Biochemical assays for the selection of cytotoxic-linked estrogens with potential therapeutic activity.

G. Leclercq, J. Heuson, 1978, Cancer treatment reports.

Therapeutic significance of sex-steroid hormone receptors in the treatment of breast cancer.

G. Leclercq, J. Heuson, 1977, European journal of cancer.

Physiological and pharmacological effects of estrogens in breast cancer.

G. Leclercq, J. Heuson, 1979, Biochimica et biophysica acta.

Assessment of response to therapy in advanced breast cancer.

R. Rubens, P. Carbone, J. Hayward, 1977, British Journal of Cancer.

Significance of quantitative assessment of estrogen receptors for endocrine therapy in advanced breast cancer

R. Sylvester, G. Leclercq, J. Heuson, 1977, Cancer.

Oestrogen receptors in human breast cancer.

G. Leclercq, J. Heuson, W. Mattheiem, 1974 .

Estrogen receptors in human breast cancer.

G. Leclercq, J. Heuson, W. Mattheiem, 1973, European Journal of Cancer.

Specific estrogen receptor of the DMBA-induced mammary carcinoma of the rat and its estrogen-requiring molecular transformation.

G. Leclercq, J. Heuson, 1973, European journal of cancer.

Growth-stimulating effect of Nafoxidine on rat mammary tumor after ovariectomy.

J. Heuson, C. Waelbroeck, G. Gallez, 1973, European journal of cancer.

Inhibition of DMBA-induced mammary carcinogenesis in the rat by 2-br- -ergocryptine (CB 154), an inhibitor of prolactin secretion, and by nafoxidine (U-11, 100 A), an estrogen antagonist.

M. L'hermite, N. Legros, C. Robyn, 1971, Gynecologic investigation.

Affinity of estradiol mustard for estrogen receptors and its enzymatic degradation in uterine and breast cancer cytosols

G. Leclercq, J. Heuson, M. Deboel, 1976, International journal of cancer.

Oestrogen receptors in male breast cancer.

G. Leclercq, A. Verhest, J. Heuson, 1976, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

Interaction of activated estradiol-receptor complex and chromatin in isolated uterine nuclei.

G. Leclercq, J. Heuson, N. Hulin, 1973, European journal of cancer.

Controlled clinical trial of L-dopa and nafoxidine in advanced breast cancer: an E.O.R.T.C. study.

L. Sobrinho, E. Engelsman, J. Heuson, 1975, British medical journal.

Tumors developing in oophorectomized Sprague-Dawley rats after a single gastric instillation of 7,12-dimethylbenz(a)anthracene.

A. Coune, J. Heuson, R. Heimann, 1968, Cancer research.

Oestrogen-induced protein in rat mammary tumour and uterus.

G. Leclercq, P. Galand, J. Heuson, 1977, The Journal of endocrinology.

Estrogen receptors in DMBA-induced rat mammary tumors before and after ovariectomy.

G. Leclercq, J. Heuson-Stiennon, J. Heuson, 1977, Oncology.

Cell proliferation induced by insulin in organ culture of rat mammary carcinoma.

A. Coune, J. Heuson, R. Heimann, 1967, Experimental cell research.

Complications of Cancer Chemotherapy. The Special Case of Hormones

J. Heuson, 1974 .

Measurement of proteolytic activity of blood with a substrate tagged with radioactive iodine.

J. Heuson, 1959, The Journal of laboratory and clinical medicine.

Letter: Breast cancer regression under oestrogen therapy.

M. L'hermite, M. Rozencweig, C. Robyn, 1974, British medical journal.

Aminoglutethimide and estrogenic stimulation before chemotherapy for treatment of advanced breast cancer. Preliminary results of a phase II study conducted by the E.O.R.T.C. Breast Cancer Cooperative Group.

R. Paridaens, J. Julien, J. van der Wijst, 1985, Journal of steroid biochemistry.

Quality control for storage and transportation of breast cancer samples for the assessment of their estrogen receptor content.

R. Paridaens, R. Sylvester, G. Leclercq, 1985, Acta clinica Belgica.

Estradiol-dependent collagenolytic enzyme activity in long-term organ culture of human breast cancer.

J. Pasteels, G. Leclercq, J. Heuson-Stiennon, 1975, Cancer research.

Androgen dependence of breast cancers.

K. Newton, H. Flax, J. Heuson, 1973, The Lancet.

Study of the growth-promoting effect of insulin in relation to carbohydrate metabolism in organ culture of rat mammary carcinoma.

N. Legros, J. Heuson, 1968, European journal of cancer.

Bulk protein secretion induced by estradiol in MCF-7 cells.

G. Leclercq, J. Heuson, N. Mairesse, 1985, European journal of cancer & clinical oncology.

Influence of insulin administration on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in intact, oophorectomized, and hypophysectomized rats.

N. Legros, J. Heuson, R. Heimann, 1972, Cancer research.

In vitro effect of testosterone and 17β‐estradiol on L‐leucine‐C14 incorporation into human breast cancer tissue

J. Heuson, N. Lecros, 1963, Cancer.

Regression of massive liver involvement by metastatic breast cancer after chemotherapy as monitored by scintigrams using a stereological method.

J. Frühling, J. Heuson, D. Gangji, 1977, European journal of cancer.

Estrogen receptor status and the clinical response to a combination of aminoglutethimide and cortisol in advanced breast cancer.

R. Paridaens, G. Leclercq, J. Heuson, 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Phenotypic change of the transplantable MXT mammary adenocarcinoma into mixed bone producing sarcoma-like tumors.

R. Kiss, R. Paridaens, A. Danguy, 1986, Anticancer Research.

Addison's disease secondary to occult metastatic seminoma: Infarction of the adrenals as the probable mechanism of their destruction

J. Heuson, 1966, Cancer.

Current overview of EORTC clinical trials with tamoxifen.

J. Heuson, 1976, Cancer treatment reports.

Use of fluorescent sex-steroid conjugates for the histochemical detection of breast cancer cell receptors: a critique.

G. Leclercq, A. Danguy, J. Heuson, 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Estrogen receptors and distribution of prognostic factors in primary breast cancer.

R. Sylvester, G. Leclercq, G. Andry, 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Cytochemical analysis of human breast cancer with fluorescent sex-steroid conjugates. Comparison with biochemical assessment of oestrogen receptors.

J. Pasteels, G. Leclercq, A. Danguy, 1981, Anticancer research.

Estrogen receptors interaction with Estracyt and degradation products, a biochemical study on a potential agent in the treatment of breast cancer

G. Leclercq, J. Heuson, M. Deboel, 1976, European Journal of Drug Metabolism and Pharmacokinetics.

Estrogen receptor variations in neoplastic tissue during the course of disease in patients with recurrent breast cancer.

R. Paridaens, R. Sylvester, G. Leclercq, 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

In vitro testing of cytotoxic compounds in hormone-dependent and -independent breast cancer cell lines.

G. Leclercq, N. Devleeschouwer, J. Heuson, 1984, Cancer treatment reviews.

Oestrogen Relevante of Cathepsin D versus Receptors in Node Negative Breast Cancers

D. Coradini, P. Carbone, J. Hayward, 1991 .

Problems in the Treatment of Disseminated Cancer of the Breast: Selection of Patients for Hormone Treatment

A. Coune, J. Heuson, H. Tagnon, 1967 .

Hodgkins' disease with massive hepatic involvement and uninvolved spleen.

J. Heuson, J. Michel, Y. Kenis, 1973, European journal of cancer.

[Adjuvant chemotherapy in breast cancer].

J. Heuson, W. Mattheiem, R. Philippon, 1971, Acta Chirurgica Belgica.

Effect of progesterone on cell proliferation in the MXT mouse hormone-sensitive mammary neoplasm.

R. Kiss, R. Paridaens, A. Danguy, 1986, Journal of the National Cancer Institute.

Relation between estrogen receptor concentration and clinical and histological factors: their relative prognostic importance after radical mastectomy for primary breast cancer.

R. Sylvester, G. Leclercq, G. Andry, 1989, European journal of cancer & clinical oncology.

Effect of castration and 17 beta-estradiol pulse on cell proliferation in the uterus and the MXT mouse mammary tumor.

R. Kiss, R. Paridaens, G. Leclercq, 1985, Journal of the National Cancer Institute.

Assessment of response to therapy in advanced breast cancer.

R. Rubens, P. Carbone, J. Hayward, 1977, British Journal of Cancer.

Part V: A Critical Summary

J. Heuson, 1984 .

In vitro effect of testosterone and 17β‐estradiol on L‐leucine‐C14 incorporation into human breast cancer tissue

J. Heuson, N. Lecros, 1963, Cancer.